FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly allergology and dermatology, and relates to a pharmaceutical composition for treating moderately severe to severe atopic dermatitis (AD) in a patient with resistance, lack of response, or an inadequate response to topical corticosteroids (TCS) or calcineurin inhibitors. Pharmaceutical composition comprises a therapeutically effective amount of an antibody to the human interleukin-4 (IL-4R) receptor or antigen-binding fragment thereof.
EFFECT: invention provides effective treatment of said pathology in a patient.
16 cl, 60 dwg, 54 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF TREATING ATOPIC DERMATITIS WITH THE HELP OF IL-4R ANTAGONIST | 2013 |
|
RU2698907C2 |
| METHOD OF TREATING SKIN INFECTION BY ADMINISTERING ANTAGONIST IL-4R | 2015 |
|
RU2704999C2 |
| METHODS FOR TREATING SEVERE ATOPIC DERMATITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2017 |
|
RU2759630C2 |
| METHOD OF TREATMENT OF ATOPIC DERMATITIS THROUGH INTRODUCTION OF IL-4R INHIBITOR | 2019 |
|
RU2801204C2 |
| METHODS FOR PREVENTING OR TREATING ALLERGIES BY INTRODUCING AN IL-4R ANTAGONIST | 2017 |
|
RU2777328C2 |
| TREATING ATOPIC DERMATITIS WITH TRADIPITANT | 2021 |
|
RU2818164C1 |
| METHODS FOR INCREASING VACCINE EFFICIENCY BY INJECTING IL-4R ANTAGONIST | 2017 |
|
RU2753869C2 |
| METHODS FOR TREATING NASAL POLYPOSIS BY ADMINISTERING IL-4R ANTAGONIST | 2014 |
|
RU2674680C2 |
| USE OF IL-13 ANTAGONISTS FOR THE TREATMENT OF ATOPIC DERMATITIS | 2017 |
|
RU2752785C2 |
| METHODS OF TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2734490C2 |
